Bruce C. Cozadd
Overview
Bruce C. Cozadd received an average of $8M in total compensation, including $738K in salary, at Jazz Pharmaceuticals from 2006 to 2021.
2021Jazz PharmaceuticalsChairperson and CEO
2020Jazz PharmaceuticalsChairman and CEO
2019Jazz PharmaceuticalsChairman and CEO
2018Jazz PharmaceuticalsChairman and CEO
2017Jazz PharmaceuticalsChairman and CEO
2016Jazz PharmaceuticalsChairman and CEO
2015Jazz PharmaceuticalsChairman and CEO
2014Jazz PharmaceuticalsChairman and CEO
2013Jazz PharmaceuticalsChairman and Chief Executive Officer
2012Jazz PharmaceuticalsChairman and Chief Executive Officer
Source: SEC filings on June 10, 2022, June 11, 2021, June 12, 2020, June 14, 2019, June 15, 2018, June 20, 2017, June 20, 2016, June 10, 2015, June 12, 2014, June 12, 2013, June 14, 2012, April 16, 2010, and October 23, 2009.
Related executives
We found 21 more executives who work or worked at Jazz Pharmaceuticals.
Daniel Swisher
Jazz Pharmaceuticals
President
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
Chris Tovey
Jazz Pharmaceuticals
Chief Operating Officer
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
Kim Sablich
Jazz Pharmaceuticals
Executive Vice President and General Manager, North America
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
Robert Iannone
Jazz Pharmaceuticals
Executive Vice President, Research and Development
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019